Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
|Active Ingredient:||Senna alexandrina 75mg equivalent to hydroxyanthracenic derivatives (Sennosides B) 15mg|
|Dosage Form:||Film coated tablet|
|New Zealand Sponsor:||CARSL Consulting|
|Manufacturer:||Laboratorios Garden House Farmaceutica S. A., San Bernardo, Chile|
|Active Ingredient:||Insulin glargine 300IU/mL equivalent to 10.91mg/mL|
|Dosage Form:||Solution for injection|
|New Zealand Sponsor:||Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics|
|Manufacturer:||Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany|
Dated this 10th day of October 2022.
MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).